ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

Advisory Groups: Nominations Sought For Director’s Consumer Liaision Group

June 13, 1997

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

July 10, 1992